Research graph
References from Effectiveness, safety, adherence and risk compensation of oral pre-exposure prophylaxis (PrEP) in men who have sex with men: a systematic review and meta-analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1001/jama.2023.9865
10.1001/jama.2023.9865 · External reference
Discontinuation, suboptimal adherence, and reinitiation of oral HIV pre-exposure prophylaxis: a global systematic review and meta-analysis
10.1016/s2352-3018(22)00030-3 · 2022 · External reference
10.1093/cid/ciy182
10.1093/cid/ciy182 · External reference
Unresolved reference
External reference
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
10.1136/bmj.n71 · 2021 · External reference
PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews
10.1186/s12913-014-0579-0 · 2014 · External reference
The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials
10.1136/bmj.d5928 · 2011 · External reference
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
10.1136/bmj.i4919 · 2016 · External reference
RoB 2: a revised tool for assessing risk of bias in randomised trials
10.1136/bmj.l4898 · 2019 · External reference
10.1097/ede.0000000000000733
10.1097/ede.0000000000000733 · External reference
10.1001/jama.280.19.1690
10.1001/jama.280.19.1690 · External reference
10.1016/j.socscimed.2017.05.049
10.1016/j.socscimed.2017.05.049 · External reference
Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations
10.1136/bmjopen-2020-048478 · 2022 · External reference
10.1097/qai.0000000000002640
10.1097/qai.0000000000002640 · External reference
10.1136/bmj.315.7109.629
10.1136/bmj.315.7109.629 · External reference
10.2307/2669529
10.2307/2669529 · External reference
10.1136/bmj.327.7414.557
10.1136/bmj.327.7414.557 · External reference
10.1097/qai.0b013e3182801081
10.1097/qai.0b013e3182801081 · External reference
10.1056/nejmoa1011205
10.1056/nejmoa1011205 · External reference
10.1016/s0140-6736(15)00056-2
10.1016/s0140-6736(15)00056-2 · External reference
10.1097/qai.0b013e31828ece33
10.1097/qai.0b013e31828ece33 · External reference
Tenofovir to Prevent HIV Infection in Western China: Pragmatic Randomized Controlled Trial
10.2196/71494 · 2025 · External reference
Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex Workers
10.1371/journal.pone.0033103 · 2012 · External reference
On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial
10.1016/s2352-3018(19)30341-8 · 2020 · External reference
HIV Seroconversion in the Era of Pharmacologic Prevention: A Case-Control Study at a San Francisco STD Clinic
10.1097/qai.0000000000002107 · 2019 · External reference
A four-year observation of HIV and sexually transmitted infections among men who have sex with men before and during pre-exposure prophylaxis in Tokyo
10.1016/j.jiac.2022.02.013 · 2022 · External reference
Association of HIV Preexposure Prophylaxis Use With HIV Incidence Among Men Who Have Sex With Men in China: A Nonrandomized Controlled Trial
10.1001/jamanetworkopen.2021.48782 · 2022 · External reference
10.2807/1560-7917.es.2022.27.14.2100591
10.2807/1560-7917.es.2022.27.14.2100591 · External reference
Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men
10.1001/jamanetworkopen.2020.30806 · 2020 · External reference
10.1097/qai.0000000000001885
10.1097/qai.0000000000001885 · External reference
Recurrent Sexually Transmitted Infections Among a Cohort of Men Who Have Sex With Men Using Preexposure Prophylaxis in Belgium Are Highly Associated With Sexualized Drug Use
10.1097/olq.0000000000001424 · 2021 · External reference
Low use of condom and high STI incidence among men who have sex with men in PrEP programs
10.1371/journal.pone.0245925 · 2021 · External reference
Misclassification of sexual health risks in a self-identified low risk cohort of men who have sex with men (MSM) enrolled in a community based PrEP program
10.1080/09540121.2019.1620167 · 2020 · External reference
10.1007/s10461-018-2252-9
10.1007/s10461-018-2252-9 · External reference
Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study
10.1016/s2352-3018(19)30136-5 · 2019 · External reference
10.1097/qad.0000000000001718
10.1097/qad.0000000000001718 · External reference
10.1136/sextrans-2017-053377
10.1136/sextrans-2017-053377 · External reference
Factors associated with PrEP-era HIV seroconversion in a 4-year U.S. national cohort of n = 6059 sexual and gender minority individuals who have sex with men, 2017-2022
10.1002/jia2.26312 · 2024 · External reference
10.1097/qad.0000000000001145
10.1097/qad.0000000000001145 · External reference
10.1097/qad.0000000000003837
10.1097/qad.0000000000003837 · External reference
10.1001/jama.2019.2591
10.1001/jama.2019.2591 · External reference
Patient and Provider Perceptions of Barriers and Facilitators to Pre-exposure Prophylaxis Access and Adherence in Black and Latinx Young Men Who Have Sex with Men
10.1089/apc.2024.0083 · 2024 · External reference
Sexual Identity Development and Social Ecological Facilitators and Barriers of PrEP Uptake and Adherence Among Latinx Men Who Have Sex with Men
10.1007/s10508-023-02776-3 · 2024 · External reference
Trajectories of anxiety and depression among Chinese men who have sex with men on pre-exposure prophylaxis: a group-based trajectory model approach
10.1186/s12889-024-17854-x · 2024 · External reference
Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings
10.1007/s11904-016-0308-x · 2016 · External reference
Trajectories of Adherence to Oral Pre-exposure Prophylaxis and Risks of HIV and Sexually Transmitted Infections
10.1093/ofid/ofae569 · 2024 · External reference
Real-world effectiveness of pre-exposure prophylaxis in men at high risk of HIV infection in France: a nested case-control study
10.1016/s2468-2667(22)00106-2 · 2022 · External reference
Estimating the impact of HIV PrEP regimens containing long-acting injectable cabotegravir or daily oral tenofovir disoproxil fumarate/emtricitabine among men who have sex with men in the United States: a mathematical modelling study for HPTN 083
2023 · External reference
10.1016/j.amepre.2021.04.036
10.1016/j.amepre.2021.04.036 · External reference
10.1093/cid/civ324
10.1093/cid/civ324 · External reference
10.1007/s11904-023-00666-w
10.1007/s11904-023-00666-w · External reference
